Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Sale of 106,563 TEVA shares, $3.63M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 106,563 | $3.63M |
| May 18, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 153,251 | $5.46M |
| Mar 9, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 19,916 | n/a |
| Mar 6, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 33,512 | n/a |
| Mar 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 49,800 | n/a |
| Mar 2, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 345,810 | $11.63M |
| Jan 29, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/Award | 141,478 | n/a |
| Jun 16, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Sale | 55,775 | $952.5K |
| Mar 7, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 21,390 | n/a |
| Mar 6, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Exercise/Conversion | 33,512 | n/a |